Global Human Rotavirus Vaccine Market In-Depth Analysis, Business Forecast and Dynamics 2024-2032

Human Rotavirus Vaccine Market Size And Forecast

Human Rotavirus Vaccine Market size was valued at USD 8.61 Billion in 2020 and is projected to reach USD 24.45 Billion by 2028, growing at a CAGR of 11.25% from 2021 to 2028.

Major factors projected to promote the growth of the Human Rotavirus Vaccine Market in the forecast period include increased development, an increase in the number of people with weakened immunity, and an increase in public awareness. Furthermore, the increase in the older population, as well as the general population and live births, are all aspects driving the Human Rotavirus Vaccine Market forward. The Global Human Rotavirus Vaccine Market report provides a holistic evaluation of the market for the forecast period. The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market.

Global Human Rotavirus Vaccine Market Definition

Rotavirus is a diarrhea-causing virus that is highly contagious. By the age of five, the majority of children had been infected with the virus at least once, before the advent of a vaccine. Even though rotavirus infections are unpleasant, they may often be treated at home with extra fluids to avoid dehydration. Severe dehydration may need receiving fluids intravenously (via a vein) in the hospital. It is vital to maintain appropriate hygiene, such as hand washing regularly. Immunization, on the other hand, is the most efficient way to avoid rotavirus infection. Within two days of the virus encounter, rotavirus infection usually sets up. The earliest signs are fever and vomiting, followed by three to seven days of watery diarrhea. The virus could also cause abdominal pain. In a healthy adult, rotavirus infection may cause only mild symptoms or none at all. Rotavirus can be discovered in a person’s face for up to ten days before symptoms appear and after they have faded.

During this time, even if the infected person is asymptomatic, the virus spreads quickly through hand-to-mouth contact. The rotavirus vaccine protects children under the age of five from rotavirus infections, which are the most common cause of severe diarrhea in children under the age of five. In both developing and developed countries, immunizations help to avoid severe diarrhea. In young children, vaccines minimize the chance of death due to diarrhea. Immunization of babies lowers disease rates among the elderly and individuals who have never been immunized. The World Health Organization (WHO) advises that the rotavirus vaccine be included in national routine vaccination programs, especially in areas where the disease is common. In addition to supporting breastfeeding, handwashing, safe drinking water, and good sanitation, these should be done. It comes in two or three dosages and is taken orally. It should be started when the child is six weeks old.

Global Human Rotavirus Vaccine Market Overview

Due to advancements in vaccine discovery and manufacturing, the Human Rotavirus Vaccine Market is quickly growing. Furthermore, the market expansion is being fueled by the growing geriatric population as well as raising public awareness. Furthermore, the rising number of immune-compromised people is another element indicating a positive outlook for the component’s growth. On the other hand, concerns about the vaccines’ side effects and cost are expected to Human Rotavirus Vaccine Market growth. The Human Rotavirus Vaccine Market is expanding due to increased vaccine production. Rotavirus immunization protects children against rotavirus infections, which cause diarrhea. Severe diarrhea, vomiting, fever, and abdominal pain are all indications of rotavirus infection, which can lead to illness. Beginning about the age of six weeks, rotavirus vaccination is given orally in two or three doses.

Increased development, an increase in the number of immunocompromised people, and an increase in public awareness are all expected to propel the Human Rotavirus Vaccine Market forward throughout the forecast period. In addition, the rise in the senior population, as well as the general population and live births, are two factors propelling the Human Rotavirus Vaccine Market forward. This increase in incidences is expected to drive the Human Rotavirus Vaccine Market during the forecast period, according to estimates. Various organizations, including UNICEF and GAVI, have urged for the use of the rotavirus vaccine in various countries to enhance immunization coverage and deliver immunizations at a lower cost, hence reducing illness instances and promoting a healthy lifestyle.

This factor is projected to contribute to the market’s growth. On the other hand, it is projected that the drop in healthcare costs in developing countries, the rise in vaccination prices, and the vaccine’s unpleasant reactions and side effects will all stymie the market’s growth soon. The potential of bioterrorism and strict regulatory standards for the approval of novel Human Rotavirus Vaccines are the main roadblocks in the Global Human Rotavirus Vaccine Market. Bioterrorism refers to the use of biological agents such as bacteria, fungi, and viruses to cause harm to humans. Because of their unpredictable nature, controlling biological agents is difficult. Because bioterrorism can easily spread through immunizations, regulatory agencies keep a careful eye on the vaccine production process to ensure no mistakes are made.

Global Human Rotavirus Vaccine Market: Segmentation Analysis

The Global Human Rotavirus Vaccine Market is Segmented on the basis of Type, Application, and Geography.

Human Rotavirus Vaccine Market, By Type

• Lanzhou Lamb
• Rotarix
• Rotavac
• Rotavin-M1
• Others

Based on Type, the market is segmented into Lanzhou Lamb, Rotarix, Rotavac, Rotavin-M1, and Others. Infections with the rotavirus are the leading cause of severe gastroenteritis in children under the age of five around the world. Two new rotavirus vaccines have recently hit the market in the United States. The rationale, development, and evaluation of Rotarix, one of these vaccines, are summarized in this article. Rotarix is a live oral rotavirus vaccination made from a single protected human strain that was attenuated by many passages in tissue culture.

Human Rotavirus Vaccine Market, By Application

• Hospitals
• Clinics
• Academic & Research Lab

Based on Application, the market is segmented into Hospitals, Clinics, and Academic & Research Lab. A thorough assessment of the market is framed by some aspects, ranging from macroeconomic conditions and business cycles in a particular country to exposing clear microeconomic repercussions. The inquiry discovered a shift in market ideal models regarding local advantage, as well as a serious scene of significant participants as a result.

Human Rotavirus Vaccine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Regional Analysis, the Global Human Rotavirus Vaccine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Americas lead the Human Rotavirus Vaccine Market due to increasing pharmaceutical use and rising healthcare prices. Moreover, the rapid adoption of new technologies, as well as the focus of major research institutions and the vaccine research sector in advanced economies, would propel the region’s Human Rotavirus Vaccine Market growth over the forecast period. The Human Rotavirus Vaccine Market in the Asia Pacific is predicted to develop significantly due to rising healthcare costs.

Key Players

The “Global Human Rotavirus Vaccine Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are GlaxoSmithKline plc, Bharat Biotech, Sanofi, Lanzhou Institute of Biologicals Products Co. Ltd, QIMR Berghofer Medical Research Institute, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Merck & Co. Inc., and Bio Farma. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Top Trending Reports: